Edition:
United Kingdom

Argos Therapeutics Inc (ARGS.OQ)

ARGS.OQ on NASDAQ Stock Exchange Capital Market

0.29USD
20 Apr 2018
Change (% chg)

$-0.04 (-12.90%)
Prev Close
$0.33
Open
$0.34
Day's High
$0.36
Day's Low
$0.27
Volume
849,926
Avg. Vol
147,911
52-wk High
$11.95
52-wk Low
$0.27

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 1.67 -8.614
Sep '17 0.05 -2.083
Jun '17 0.07 -4.127
Mar '17 0.11 -11.657
FY 2016 Dec '16 0.16 -4.582
Sep '16 0.15 -11.830
Jun '16 0.49 -9.672
Mar '16 0.15 -11.342
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.05 0.05 0.05 --
Quarter Ending Sep-18 1 0.05 0.05 0.05 --
Year Ending Dec-18 1 0.20 0.20 0.20 9.92
Earnings (per share)
Quarter Ending Jun-18 1 -1.80 -1.80 -1.80 --
Quarter Ending Sep-18 1 -1.80 -1.80 -1.80 --
Year Ending Dec-18 1 -7.00 -7.00 -7.00 -16.67
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.95 32.74
P/E High - Last 5 Yrs. -- 40.70 45.72
P/E Low - Last 5 Yrs. -- 23.63 24.22
Beta 1.34 0.89 0.88
Price to Sales (TTM) 20.16 3.94 5.71
Price to Book (MRQ) -- 4.80 5.37
Price to Tangible Book (MRQ) -- 5.61 6.95
Price to Cash Flow (TTM) -- 22.91 23.32
% Owned Institutions 9.44 1.21 2.17

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.47 5.32
Payout Ratio(TTM) -- 45.35 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -85.74 3.69 9.21
Sales (TTM) vs TTM 1 Yr. Ago -44.04 4.83 5.69
Sales - 5 Yr. Growth Rate -34.16 10.08 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 57.33 16.36 19.36
EPS (TTM) vs TTM 1 Yr. Ago 43.78 -- --
EPS - 5 Yr. Growth Rate -- 9.87 10.76
Capital Spending - 5 Yr. Growth Rate 128.88 15.52 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.12 2.19
Current Ratio (MRQ) 1.51 2.90 2.98
LT Debt to Equity (MRQ) -- 9.88 12.18
Total Debt to Equity (MRQ) -- 13.86 16.45
Interest Coverage (TTM) -31.06 35.89 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.81 54.44
Gross Margin - 5 Yr. Avg. -- 52.15 52.20
EBITD Margin (TTM) -9,409.45 -- --
EBITD - 5 Yr. Avg -1,435.49 18.57 10.96
Operating Margin (TTM) -16,425.43 14.36 4.73
Operating Margin - 5 Yr. Avg. -1,462.72 14.52 6.40
Pre-Tax Margin (TTM) -12,407.62 14.82 5.57
Pre-Tax Margin - 5 Yr. Avg. -1,446.56 14.90 6.81
Net Profit Margin (TTM) -12,407.62 11.08 1.87
Net Profit Margin - 5 Yr. Avg. -1,446.56 11.20 3.09
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.42 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,978 938,079,949 846,830,978
Net Income/Employee (TTM) -493,610 110,368,367 99,616,195
Receivable Turnover (TTM) 1.93 5.63 5.78
Inventory Turnover (TTM) -- 2.59 3.35
Asset Turnover (TTM) 0.01 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -130.36 11.40 10.95
Return on Assets - 5 Yr. Avg. -100.93 12.91 12.31
Return on Investment (TTM) -200.62 14.84 14.38
Return on Investment - 5 Yr. Avg. -133.29 16.88 16.10
Return on Equity (TTM) -- 16.34 16.07
Return on Equity - 5 Yr. Avg. -- 17.98 17.39
  1 Year 3 Year 5 Year
Sales % 82.41 -40.20 -34.16
EPS (TTM) % 54.68 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Argos Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.56%
# of Holders: 33
Total Shares Held: 288,262
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.